30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Nika Pharmaceuticals Inc (NIKA)

Track

The most recent insider trading activity at Nika Pharmaceuticals Inc. involved a proposed sale of 10,000,000 shares valued at $10,000,000 on April 16, 2025, by Officer, Director, and 10% Stockholder Savov Dimitar Slavchev. Prior to this, on March 18, 2025, the CEO, CFO, and President, Savov Dimitar Slavchev, sold 2,000,000 shares for $500,000.
Stock chart
Ticker: NIKA Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Savov Dimitar Slavchev
Officer; Director; 10% Stockholder
1 sale — total 10,000,000 USD
Proposed sale 16 Apr 2025
Value US$2,840,516.91 | Price 336.78 | Shares 36,450
Sale 18 Mar 2025
Value US$2,675,423.37 | Price 44.10 | Shares 1,958
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-16 2025-04-16 PrS Proposed sale
Savov Dimitar Slavchev

Officer; Director; 10% Stockholder

Executive Director Large shareholder
36,450
336.78
US$2,840,517 		36,450 336.78 US$2,840,517
2025-03-19 2025-03-18 S Sale
Savov Dimitar Slavchev

CEO, CFO, President

Executive Director Large shareholder
1,958 -4.7%
44.10
US$2,675,423 		1,958 -4.7% 44.10 US$2,675,423
Explore more

More insider trading research around Nika Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America